Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.016 0.002 (14.29%) Market Cap: 993,000.00 Enterprise Value: 43.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2020 Evofem Biosciences Inc Earnings Call Transcript

Mar 04, 2021 / 09:30PM GMT
Release Date Price: $6131.22 (-9.17%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Evofem's Fourth Quarter and Year-end 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your host, Amy Raskopf. Please, go ahead.

Amy Raskopf
Evofem Biosciences, Inc. - Head of IR

Thank you. Hi, everyone. This is Amy Raskopf, and Evofem Biosciences' Vice President of Investor Relations. Thank you for participating in today's call. If you haven't done so already, I encourage you to access our Q4 and year-end 2020 presentation and the press release we issued earlier this afternoon, both of which are at evofem.investorroom.com/q4ye2020results.

During this call, we will make forward-looking statements regarding the company's future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot